Furthermore, owing to its selective expression in repaired or reshaped tissues, FAP is considered a biomarker for activating fibroblasts in arthritis, autoimmune disorders, cardiovascular diseases (CVD), fibrosis, and metabolic diseases (21), since these nonmalignant diseases show an upgraded expression of FAP, which is associated with disease progression (20–23). Here, FAP is linked to metabolic disease.